Grounded in more than 30 years of experience in dental pharmacology, dental malpractice analysis, biochemistry, and healthcare-related drug safety issues, this dental malpractice expert witness specializes in opioid prescribing practices, dental pharmacology errors, dental infections, antibiotic prophylaxis protocols, implant-related complications, dental fraud, and wrongful death matters involving dental treatment and medication management. The expert’s background also includes evaluation of recreational and medical marijuana use, hallucinogens and psychedelics, cannabinoid pharmacology, vaping-related health issues, and substance-related clinical risk factors affecting healthcare treatment and patient safety. Additional areas of expertise include laser-related dental injuries, dental laser burns, photobiology, wearable medical technologies, and pharmacologic considerations associated with pain management, addiction, and polysubstance use disorders.

Extensive litigation and consulting experience includes participation in depositions and courtroom testimony for more than 30 years and service as an expert witness in more than 30 malpractice and civil litigation matters across the United States. Litigation-related work has included opioid prescribing cases against dental professionals, wrongful death dental pharmacology matters, DEA and state licensure board investigations, dental infection claims, dental malpractice mitigation issues, and evaluation of prescribing practices involving opioids, cannabis products, and other controlled substances. The expert has additionally provided pharmacology-related consultation involving medical marijuana, hallucinogens, psychedelics, vaping products, and polysubstance use issues in healthcare and professional liability contexts.

Leadership experience includes serving as Chief Scientific Officer and Chief Medical Officer for a medical technologies organization focused on light-based and medical device technologies, including technologies associated with FDA-cleared medical device and drug applications, as well as ownership and operation of a dental practice and service as Chief Dental Officer for a maxillofacial imaging center. The expert’s professional work has also involved development and delivery of accredited continuing education programs for physicians, dentists, pharmacists, nurses, addiction counselors, psychologists, social workers, and other healthcare professionals throughout the United States. Over the last 6 years, the expert has delivered more than 1,000 continuing education lectures to over 150,000 healthcare professionals addressing opioid use, dental pharmacology, cannabinoids, psychedelics, hallucinogens, vaping, circadian medicine, and substance-related clinical safety concerns.

Professional credentials include licensure as a Doctor of Dental Medicine and completion of a General Practice Residency. Educational background includes a Doctor of Dental Medicine degree and a Bachelor of Science degree in Biochemistry. Professional contributions include authorship of continuing education coursework, published articles involving opioid prescribing malpractice implications, marijuana-related health risks, vaping concerns, circadian medicine, and cannabis-related safety issues, along with creation of accredited educational programs approved by pharmacy, nursing, psychology, physical therapy, occupational therapy, and other professional licensing boards. Additional research and development activities have involved wearable medical technologies, pharmacologic technologies, laser and light-based medical systems, and healthcare safety education initiatives.